Evidence shows that RT enhances the reactivation of CD8+ T cells against NSCLC through specifically inhibiting phosphorylation of STAT1 and STAT3 and reducing the IFNγ-mediated anti-apoptosis MCL1 expression. Here, CD8A is linked to non-small cell lung carcinoma.